New oral cancer vaccine passes phase I safety study

A research group including Professor Toshiro Shirakawa of the Graduate School of Science, Technology and Innovation and Professor Hideaki Miyake and Dr. Hideto Ueki of the Graduate School of Medicine at Kobe University conducted a Phase I investigator-initiated clinical trial of the oral cancer vaccine B440 in patients with metastatic urothelial carcinoma whose disease had progressed after…